United Health Products, Inc. (UEEC)
| Market Cap | 9.61M -50.9% |
| Revenue (ttm) | n/a |
| Net Income | -1.42M |
| EPS | -0.01 |
| Shares Out | 263.29M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 414,416 |
| Open | 0.0349 |
| Previous Close | 0.0340 |
| Day's Range | 0.0340 - 0.0412 |
| 52-Week Range | 0.0285 - 0.1200 |
| Beta | -0.25 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |
About United Health Products
United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers CelluSTAT hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as... [Read more]
Financial Performance
Financial StatementsNews
United Health Products Quarterly report: Q3 2025
United Health Products has published its Q3 2025 quarterly earnings report on November 14, 2025.
United Health Products to Present at the Life Sciences Virtual Investor Forum September 18th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as ...
United Health Products Quarterly report: Q2 2025
United Health Products has published its Q2 2025 quarterly earnings report on August 14, 2025.
United Health Products Quarterly report: Q1 2025
United Health Products has published its Q1 2025 quarterly earnings report on May 5, 2025.
United Health Products Annual report: Q4 2024
United Health Products has published its Q4 2024 annual report on March 28, 2025.
United Health Products provides update on clinical study process
United Health Products (UEEC) provided an update on the company’s planned clinical study. As previously disclosed, United Health Products is conducting a clinical trial of its CelluSTAT Hemostatic Gau...
United Health Products Provides Update on Clinical Study Process
MT. LAUREL, N.J., Dec. 02, 2024 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's planned clinical study.
United Health Products Quarterly report: Q3 2024
United Health Products has published its Q3 2024 quarterly earnings report on November 12, 2024.
United Health Products provides update on PMA application
United Health Products (UEEC) provided an update on the company’s FDA Premarket Approval application process. Following the company’s August 15, 2024 submission of its Submission Issue Request to the ...
United Health Products submits response letter to FDA
United Health Products provided an update on the company’s FDA Premarket Approval application process. Following the company’s March 21 submission of its PMA application and the FDA’s June 18 “Deficie...
United Health Products Submits Response Letter to FDA
MT. LAUREL, NJ, Aug. 19, 2024 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval (PMA) application process.
United Health Products Quarterly report: Q2 2024
United Health Products has published its Q2 2024 quarterly earnings report on August 13, 2024.
United Health Products Quarterly report: Q1 2024
United Health Products has published its Q1 2024 quarterly earnings report on May 9, 2024.
United Health Products Annual report: Q4 2023
United Health Products has published its Q4 2023 annual report on April 1, 2024.
United Health Products submits full Premarket Approval application
United Health Products provided an update on the company’s FDA Premarket Approval application process. The company confirms that it has submitted via the FDA eSTAR portal its Premarket Approval applic...
United Health Products Submits Full FDA PMA Application
MOUNT LAUREL, NJ, March 21, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval application process...
United Health Products to proceed with final drafting of PMA documentation
United Health Products reports on the receipt and review of final reports on product sterilization and stability testing for its hemostatic gauze. As previously disclosed, UHP has been working with…
United Health Products Reports on FDA Application Status
MESQUITE, NV, Jan. 19, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products (UEEC) reports today on the receipt and review of final reports on product sterilization and stability testing...
The Medicare Gold Rush Is Slowing Down
UnitedHealth's disappointing outlook and the Humana sale talks intensify concerns that the Medicare Advantage business isn't what it once was.
United Health Products Quarterly report: Q3 2023
United Health Products has published its Q3 2023 quarterly earnings report on November 13, 2023.
United Health Products Quarterly report: Q2 2023
United Health Products has published its Q2 2023 quarterly earnings report on August 9, 2023.
United Health Products reports on product testing for FDA application
United Health Products provided an update on the company’s FDA Premarket Approval application process. Due to further unanticipated delays in testing performed by external service providers, the compa...
United Health Products Reports on Product Testing for FDA Application
MESQUITE, NV, Aug. 04, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval application process.
United Health Products Reports on Progress in Product Testing
MESQUITE, NV, June 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval application process.
United Health Products Reiterates Guidance on FDA PMA Application Process
MESQUITE, NV, June 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval application process.